Critical study of prognostic factors in childhood acute lymphoblastic leukaemia: differences in outcome are poorly explained by the most significant prognostic variables-Reference-Cited by-同舟云学术

Critical study of prognostic factors in childhood acute lymphoblastic leukaemia: differences in outcome are poorly explained by the most significant prognostic variables

Published:1998-08 Issue:3 Volume:102 Page:729-739
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:British Journal of Haematology

Author:

Donadieu Jean,Auclerc Marie-FranÇoise,Baruchel AndrÉ,Leblanc Thierry,Landman-Parker Judith,Perel Yves,Michel Gérard,Cornu Gérard,Bordigoni Pierre,Sommelet Danielle,Leverger Guy,Hill Catherine,Schaison for the Fralle group Gérard

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.1998.00818.x/fullpdf

Reference58 articles.

1. Good steroid response in vivo predicts a favorable outcome in children with T-cell acute lymphoblastic leukemia;Arico;Cancer,1995

2. Treatment results of the EORTC-Children's leukemia cooperative group (CLCG) protocols 58831/2 in 177 children with T-cell lymphoblastic leukemia or non-Hodgkin lymphoma;Bahner-Ennassih;Annals of Hematology,1995

3. Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance;Campana;Blood,1995

4. Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X;Chessells;Lancet,1995

5. Collet , D. 1994 Modelling Survival Data in Medical Research

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted sequencing reveals the relationship between mutations and patients’ clinical indicators, blood cell counts and early progression in diffuse large-B cell lymphoma;Leukemia & Lymphoma;2022-10-10

2. The pretreatment platelet count predicts survival outcomes of diffuse large B-cell lymphoma: An analysis of 1007 patients in the rituximab era;Leukemia Research;2021-11

3. Optimizing therapy in the modern age: differences in length of maintenance therapy in acute lymphoblastic leukemia;Blood;2021-01-14

4. Safety of intrathecal route: focus to methylprednisolone acetate (Depo-Medrol) use;European Spine Journal;2017-11-18

5. Utility of a simple prognostic stratification based on platelet counts and serum albumin levels in elderly patients with diffuse large B cell lymphoma;Annals of Hematology;2016-09-19